A patient presenting with cholangitis due to Stenotrophomonas maltophila and pseudomonas aeruginosa successfully treated with intrabiliary colistine

Infectious Disease Reports

Volumn 6, Issue 2, 2014, Pages 17-19

  Pérez, Pablo N ^a   Ramírez, María A ^b   Fernández, José A ^a   de Guevara, Laura Ladrón ^c  

^a Hospital Angeles Clinica Londres   (Mexico)

^b NATIONAL INSTITUTE OF NEUROLOGY AND NEUROSURGERY   (Mexico)

^c Hospital 20 de Noviembre   (Mexico)

Author keywords

Cholangitis; Colistine; Pseudomonas; Stenotrophomonas

Indexed keywords

ANTIBIOTIC AGENT; BILIRUBIN; CARBAPENEM; CEFALEXIN; CILASTATIN PLUS IMIPENEM; COLISTIMETHATE; COLISTIN; CREATININE; FOSFOMYCIN; HEMOGLOBIN; MEROPENEM; TIGECYCLINE;

ADULT; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIUM ISOLATION; BILE DUCT BYPASS; BILIARY CATHETER; BILIARY CIRRHOSIS; BILIARY TRACT DRAINAGE; BILIRUBIN BLOOD LEVEL; CASE REPORT; CHOLANGITIS; CREATININE BLOOD LEVEL; DISEASE EXACERBATION; DOSE RESPONSE; DRUG SUBSTITUTION; DRUG WITHDRAWAL; ECHOGRAPHY; EXTENDED SPECTRUM BETA LACTAMASE PRODUCING ESCHERICHIA COLI; FEMALE; FEVER; FOLLOW UP; HEMOGLOBIN BLOOD LEVEL; HUMAN; JAUNDICE; LOADING DRUG DOSE; MALAISE; MEAN CORPUSCULAR HEMOGLOBIN; MEDICAL HISTORY; MIDDLE AGED; PSEUDOMONAS AERUGINOSA; RECURRENT DISEASE; STENOTROPHOMONAS MALTOPHILIA; TREATMENT DURATION; ABDOMINAL PAIN; ANTIMICROBIAL THERAPY; BACTERIUM DETECTION; BLOOD CELL COUNT; ESCHERICHIA COLI INFECTION; INTRABILIARY DRUG ADMINISTRATION; NONHUMAN; PSEUDOMONAS INFECTION;

EID: 84900407041     PISSN: None     EISSN: 20367449     Source Type: Journal    
DOI: 10.4081/idr.2014.5147     Document Type: Article

References (14)

1. Rice LB. Federal funding for the study of antimicrobial resistance in nosocomial pathogens: no ESKAPE. J Infect Dis 2008;197:1079-81.
2. Pendleton JN, Gorman SP, Gilmore BF. Clinical relevance of the ESKAPE pathogens. Expert Rev Anti Infect Ther 2013;11:297-308.
3. Brooke JS. Stenotrophomonas maltophila: an emerging global opportunistic pathogen. Clin Microbiol Rev 2012;25:2-41.
4. Fihman V, Le Monnier A, Corver S, et al. Stenotrophomonas maltophila-the most worrisome threat among unusual non-fermentative gram-negative bacilli from hospitalized patients: a prospective multicenter study. J Infect 2012;64:391-8.
5. Englesbe MJ, Dawes LG. Resistant pathogens in biliary obstruction: importance of cultures to guide antibiotic therapy. HPB (Oxford) 2005;7:144-8.
6. Sung YK, Lee JK, Lee KH, et al. The clinical epidemiology and outcomes of bacteremic biliary tract infections caused by antimicrobial-resistant pathogens. Am J Gastroenterol 2012;107:473-83.
7. Goo JC, Seong MH, Shim YK, et al. Extended spectrum-β-lactamase or carbapenemase producing bacteria isolated from patients with acute colangitis. Clin Endosc 2012;45:155-60.
8. Rösch T, Triptrap A, Born P, et al. Bacterobilia in percutaneous transhepatic biliary drainage: occurrence over time and clinical sequelae. Scand J Gastroenterol 2003;11:1162-8.
9. N'Guyen Y, Hentzien M, Goehringe F, et al. Utilisation de la colimycine pour le traitement d'angiocholites à Pseudomonas aeruginosa multirèsistants. Med Mal Infect 2012;42:366-9.
10. Farrell DJ, Sader HS, Jones RN. Antimicrobial susceptibilities of a worldwide collection of Stenotrophomonas maltophila isolates tested against ticecycline and agents commonly used for S. maltophila infection. Antimicrob Agents Chemother 2010;54:2735-7.
11. Ng J, Gosbell IB, Kelly JA, et al. Cure of multiresistant Acinetobacter baumannii central nervous system infections with intraventricular or intrathecal colistin: case series and literature review. J Antimicrob Chemother 2006; 58:1078-81.
12. Falagas ME, Bliziotis IA, Tam VH. Intraventricular or intrathecal use of polymyxins in patients with Gram-negative meningitis: a systematic review of the available evidence. Int J Antimicrob Agents 2007;29:9-25.
13. Volkow P, Franco C, Cornejo P. Intravesical colistin irrigation to treat multidrugresistant Acinetobacter baumannii urinary tract infection: a case report. J Med Case Rep 2012;6:426-7.
14. Giua R, Pedone C, Cortese L, Incalzi RA. Colistin bladder instillation, an alternative way of treating multi-resistant Acinetobacter urinary tract infection: a case series and review of literature. Infection 2014;42:199-202.